Advocacy webinar

The COVID-19 pandemic is transforming the world around us—shifting priorities, repurposing resources, changing accountability practices, and accelerating policy development. In the absence of face-to-face interaction, the pandemic is also changing the way health advocates approach policymakers—increasingly through virtual means. Virtual engagements are often more difficult at the subnational level, excluding critical community and civil society voices in decision-making. 

As decision-making, accountability, and action is increasingly taking place subnationally, how must our ‘traditional’ approaches to advocating at the subnational level shift as a result of the pandemic? How can we facilitate and ensure community perspectives feed into national decision-making? How can we improve the capacity of sub-national level advocates for impactful engagement in the new normal?

We hope to explore these and more questions in the second conversation in PATH’s virtual learning series: Health Advocacy in the New Normal. This series aims to catalyze conversations and exchange best practices among health advocates and policymakers by bringing together perspectives from across the African continent to reflect upon what is working and how we are evolving the practice of advocacy for impact in the health sector.

Event Details:

Date: August 6, 2020

Time: 4:00-5:30 PM EAT | 9:00-10:30 AM EST

Venue: Virtual

Regions of primary focus: Africa

Registration link: https://path.zoom.us/webinar/register/WN_TVjZu3NDRxK9vtu_eqzgKA

Speakers:

Christina Chilimba, Youth Champion, Graça Machel Trust, Malawi

Dr. Andrew Mulwa, Minister for Health Services, Makueni County, Kenya

George Osei-Bimpeh, Country Director, SEND-GHANA, Ghana

​Moderated by Melissa Wanda, Advocacy and Policy Officer, PATH, Kenya

With contributions from Monica Ogutu, Executive Director, Kisumu Medical and Education Trust, Kenya

 

Register here

Please Read Advocacy Learning Lab: Decentralization Meeting Report prior to webinar for more effective.

LEAVE A REPLY

Please enter your comment!
Please enter your name here